These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 183099)
1. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung. Fertel R; Weiss B Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099 [No Abstract] [Full Text] [Related]
2. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators? Strada SJ; Thompson WJ Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379 [No Abstract] [Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase from Spinacea oleracea L: subcellular distribution and properties [proceedings]. Edwards M; Brown EG; Newton RP; Smith CJ Biochem Soc Trans; 1977; 5(4):975-7. PubMed ID: 199507 [No Abstract] [Full Text] [Related]
4. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples. Kang ES Pediatr Res; 1978 Jul; 12(7):761-6. PubMed ID: 211480 [No Abstract] [Full Text] [Related]
5. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182 [No Abstract] [Full Text] [Related]
6. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones. Goff AK; Major PW FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943 [No Abstract] [Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases of human and rat gastric mucosa. Klotz U; Antonin KH; Bieck P Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):187-90. PubMed ID: 189231 [No Abstract] [Full Text] [Related]
10. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Netherton SJ; Maurice DH Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573 [TBL] [Abstract][Full Text] [Related]
11. Presence of a calcium2+-dependent activator of cyclic-nucleotide phosphodiesterase in rat carotid body: effects of hypoxia. Hanbauer I; Lovenberg W Neuroscience; 1977; 2(4):603-7. PubMed ID: 199858 [No Abstract] [Full Text] [Related]
12. Cyclic nucleotide phosphodiesterase activity in normal mice and mice with retinal degeneration. Robb RM Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1097-100. PubMed ID: 225287 [No Abstract] [Full Text] [Related]
13. Inhibitory and activators of cyclic nucleotide phosphodiesterase. Chasin M; Harris DN Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316 [No Abstract] [Full Text] [Related]
14. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. Levin RM; Weiss B Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095 [No Abstract] [Full Text] [Related]
15. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine. Sugden MC; Ashcroft SJ Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834 [TBL] [Abstract][Full Text] [Related]
20. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue. Green D; Guy G; Moore JB Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714 [No Abstract] [Full Text] [Related] [Next] [New Search]